ClinVar Miner

Submissions for variant NM_024577.3(SH3TC2):c.1972C>T (p.Arg658Cys) (rs80338926)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000236498 SCV000292951 likely pathogenic not provided 2018-02-23 criteria provided, single submitter clinical testing The R658C missense variant in the SH3TC2 gene has been reported previously in multiple families with CMT, at least two of whom who were also heterozygous for the R954X pathogenic variant (Senderek et al.,2003; Azzedine et al., 2006; Lassuthova et al., 2011). Functional studies show that R658C alters protein localization (Lupo et al., 2009; Roberts et al., 2010). This variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The R658C variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position where amino acids with similar properties to Arginine are tolerated across species. Based on currently available evidence, R658C is a strong candidate for a pathogenic variant. However, the possibility it may be a rare benign variant cannot be excluded.
Invitae RCV000654080 SCV000775970 pathogenic Charcot-Marie-Tooth disease type 4 2019-08-28 criteria provided, single submitter clinical testing This sequence change replaces arginine with cysteine at codon 658 of the SH3TC2 protein (p.Arg658Cys). The arginine residue is highly conserved and there is a large physicochemical difference between arginine and cysteine. This variant is present in population databases (rs80338926, ExAC 0.01%). This variant has been found to segregate with Charcot-Marie-Tooth disease type 4C in affected families. It has also been observed in several affected individuals (PMID: 14574644, 21291453, 22462672, 16924012). ClinVar contains an entry for this variant (Variation ID: 21690). Experimental studies have shown that this missense change impacts SH3TC2 cellular localization in vitro (PMID: 19744956). For these reasons, this variant has been classified as Pathogenic.
CeGaT Praxis fuer Humangenetik Tuebingen RCV000236498 SCV001249578 pathogenic not provided 2016-10-01 criteria provided, single submitter clinical testing
Molecular Genetics Laboratory,London Health Sciences Centre RCV001173151 SCV001336228 likely pathogenic Charcot-Marie-Tooth disease criteria provided, single submitter clinical testing
Knight Diagnostic Laboratories, Oregon Health and Sciences University RCV001270096 SCV001448914 likely pathogenic Mononeuropathy of the median nerve, mild 2018-05-11 criteria provided, single submitter clinical testing
GeneReviews RCV000020888 SCV000041484 pathologic Charcot-Marie-Tooth disease, type 4C 2008-03-31 no assertion criteria provided curation Converted during submission to Pathogenic.
Equipe Genetique des Anomalies du Developpement, Université de Bourgogne RCV000020888 SCV001190290 likely pathogenic Charcot-Marie-Tooth disease, type 4C 2019-08-21 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.